Bengaluru, India

Anoop Chullikana House

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Stempeutics Research Pvt. Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anoop Chullikana House. Retrieved from https://idiyas.com/inventor/anoop-chullikana-house

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anoop Chullikana House: Innovator in Ischemia Management

Introduction

Anoop Chullikana House is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medical innovation, particularly in ischemia management. His inventive work focuses on utilizing mesenchymal stromal cells (MSCs) to develop advanced treatment solutions.

Latest Patents

Anoop holds a patent titled "Management of Ischemia Using Pooled Mesenchymal Stromal Cell Composition." This patent reveals a groundbreaking composition consisting of pooled and expanded allogeneic mesenchymal stromal cells. The described method aims to manage ischemic conditions effectively. The innovation emphasizes the use of bone marrow-derived MSCs with efficient dosage ranges and administration routes, alongside a conditioned medium rich in bioactive factors to enhance management outcomes.

Career Highlights

Anoop Chullikana House is currently associated with Stempeutics Research Pvt. Ltd., a company at the forefront of stem cell research and therapeutic applications. His role at the company involves pioneering research that blends cellular biology with medical advancements, particularly in regenerative medicine.

Collaborations

Throughout his career, Anoop has worked alongside esteemed colleagues, including Anish Sen Majumdar and Pawan Kumar Gupta. Together, they contribute significantly to the innovative research and development efforts at Stempeutics, pushing the boundaries of what is possible in patient care through advancements in stem cell therapy.

Conclusion

Anoop Chullikana House exemplifies the spirit of innovation in medicine through his dedicated research in managing ischemic conditions. His patent not only showcases his inventive capabilities but also provides a promising avenue for future treatments that leverage the power of mesenchymal stromal cells. As the field evolves, contributions from innovators like Anoop will undoubtedly play a crucial role in shaping the future of medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…